Ulteriori informazioni
In this issue of Clinics in Laboratory Medicine, guest editors Drs. Daimon P. Simmons and Peter H. Schur bring their considerable expertise to the topic of Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19. Top experts in the field cover key topics such as performance of central lab assays to detect SARS-COV-2 antibodies; alternative methods to detect SARS-CoV-2 antibodies; the role of antibodies in developing vaccines for COVID-19; SARS-COV-2 antibodies after immunization; and more.
- Contains 9 relevant, practice-oriented topics including disease-specific alterations in the cellular bases of the humoral immune response in COVID-19; coronavirus antigens as targets of antibody responses; approaches for SARS-CoV-2 antibody testing in a reference lab; use of IgM, IgA, and IgG in treatment and prognosis of patients with COVID-19; performance of lateral flow assays for COVID-19 serology; and more.
- Provides in-depth clinical reviews on detection of SARS-CoV-2 antibodies in diagnosis and treatment of COVID-19, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Sommario
Severe Acute Respiratory Syndrome Coronavirus 2 Serology Testing - A Laboratory PrimerPerformance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization: A ReviewPerformance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 SerologyAlternative Methods to Detect Severe Acute Respiratory Syndrome Coronavirus 2 AntibodiesSuboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant GenerationAntibody Dynamics and Durability in Coronavirus Disease-19Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody ResponsesVaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)
